Literature DB >> 10335445

Molecular studies on the toxifying effects by genetically engineered cytochromes P450.

J Doehmer1, J T Buters, A Luch, V Soballa, W M Baird, H Morisson, J J Stegeman, A J Townsend, W F Greenlee, H R Glatt, A Seidel, J Jacob, H Greim.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10335445     DOI： 10.1081/dmr-100101928

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN： 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  3 in total

1.  Establishment of a human hepatocyte line (OUMS-29) having CYP 1A1 and 1A2 activities from fetal liver tissue by transfection of SV40 LT.

Authors:  K Fukaya; S Asahi; S Nagamori; M Sakaguchi; C Gao; M Miyazaki; M Namba
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-05       Impact factor: 2.416

2.  Heterologous expression of equine CYP3A94 and investigation of a tunable system to regulate co-expressed NADPH P450 oxidoreductase levels.

Authors:  Ramona Dettwiler; Andrea L Schmitz; Philippe Plattet; Jana Zielinski; Meike Mevissen
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

3.  Functional impact of cytochrome P450 3A (CYP3A) missense variants in cattle.

Authors:  Mery Giantin; Minna Rahnasto-Rilla; Roberta Tolosi; Lorena Lucatello; Marianna Pauletto; Giorgia Guerra; Francesca Pezzato; Rosa M Lopparelli; Roberta Merlanti; Paolo Carnier; Francesca Capolongo; Paavo Honkakoski; Mauro Dacasto
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.